These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7792434)

  • 1. Nebulizer performance: AFLM study. Association Française de Lutte contre la Mucoviscidose.
    Faurisson F; Dessanges JF; Grimfeld A; Beaulieu R; Kitzis MD; Peytavin G; Lefebvre JP; Farinotti R; Sautegeau A
    Respiration; 1995; 62 Suppl 1():13-8. PubMed ID: 7792434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of the performance and ergonomics of nebulizers in cystic fibrosis].
    Faurisson F; Dessanges JF; Grimfeld A; Beaulieu R; Kitzis MD; Peytavin G; Lefevre JP; Farinotti R; Sautegeau A
    Rev Mal Respir; 1996; 13(2):155-62. PubMed ID: 8711234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nebulizer configuration on delivery of aerosolized tobramycin.
    O'Riordan TG; Amram JC
    J Aerosol Med; 1997; 10(1):13-23. PubMed ID: 10166359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer.
    Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW
    Int J Pharm; 1999 Nov; 189(2):205-14. PubMed ID: 10536249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalation of tobramycin in cystic fibrosis. Part 2: optimization of the tobramycin solution for a jet and an ultrasonic nebulizer.
    Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW
    Int J Pharm; 1999 Nov; 189(2):215-25. PubMed ID: 10536250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
    Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A
    Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nebulizer type and antibiotic concentration on device performance.
    Weber A; Morlin G; Cohen M; Williams-Warren J; Ramsey B; Smith A
    Pediatr Pulmonol; 1997 Apr; 23(4):249-60. PubMed ID: 9141110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characterization by isotope method of the performance of the pneumatic nebulizer NL9 Atomizer in the production of colistin, tobramycin and amiloride aerosols].
    Diot P; Le Pape A; Boissinot E; Lemarié E
    Rev Mal Respir; 1994; 11(6):573-8. PubMed ID: 7831507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design principles of liquid nebulization devices currently in use.
    Rau JL
    Respir Care; 2002 Nov; 47(11):1257-75; discussion 1275-8. PubMed ID: 12425742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers.
    Sidler-Moix AL; Dolci U; Berger-Gryllaki M; Pannatier A; Cotting J; Di Paolo ER
    Pediatr Crit Care Med; 2013 Feb; 14(2):e98-102. PubMed ID: 23287904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems. Aerosolized Tobramycin Study Group.
    Eisenberg J; Pepe M; Williams-Warren J; Vasiliev M; Montgomery AB; Smith AL; Ramsey BW
    Chest; 1997 Apr; 111(4):955-62. PubMed ID: 9106575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols.
    Coates AL; MacNeish CF; Meisner D; Kelemen S; Thibert R; MacDonald J; Vadas E
    Chest; 1997 May; 111(5):1206-12. PubMed ID: 9149571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro characteristics of tobramycin aerosol from ultrasonic and jet nebulizers.
    Asmus MJ; Milavetz G; Tice AL; Teresi ME
    Pharmacotherapy; 2001 May; 21(5):534-9. PubMed ID: 11349742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposable versus reusable jet nebulizers for cystic fibrosis treatment with tobramycin.
    Vecellio L; Abdelrahim ME; Montharu J; Galle J; Diot P; Dubus JC
    J Cyst Fibros; 2011 Mar; 10(2):86-92. PubMed ID: 21075063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the availability of tobramycin for inhalation from vented vs unvented nebulizers.
    Coates AL; MacNeish CF; Lands LC; Meisner D; Kelemen S; Vadas EB
    Chest; 1998 Apr; 113(4):951-6. PubMed ID: 9554630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro comparison of five nebulizers during noninvasive ventilation: analysis of inhaled and lost doses.
    Michotte JB; Jossen E; Roeseler J; Liistro G; Reychler G
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):430-40. PubMed ID: 24517084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolization of tobramycin (TOBI) with the PARI LC PLUS reusable nebulizer: which compressor to use? Comparison of the CR60 to the PortaNeb compressor.
    Westerman EM; Boer AH; Touw DJ; Brun PP; Roldaan AC; Frijlink HW; Heijerman HG
    J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):269-80. PubMed ID: 18759658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro aerodynamic characterization of the dose emitted during nebulization of tobramycin high strength solution by novel and jet nebulizer delivery systems.
    Mashat M; Clark BJ; Assi KH; Chrystyn H
    Pulm Pharmacol Ther; 2016 Apr; 37():37-42. PubMed ID: 26747025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung deposition in cystic fibrosis patients using an ultrasonic or a jet nebulizer.
    Köhler E; Sollich V; Schuster-Wonka R; Hühnerbein J
    J Aerosol Med; 2003; 16(1):37-46. PubMed ID: 12737683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accounting for radioactivity before and after nebulization of tobramycin to insure accuracy of quantification of lung deposition.
    Coates AL; Dinh L; MacNeish CF; Rollin T; Gagnon S; Ho SL; Lands LC
    J Aerosol Med; 2000; 13(3):169-78. PubMed ID: 11066020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.